These findings are in accordance with previous studies which revealed that SNAT1 promotes proliferation and tumor growth in colorectal cancer [16], breast cancer [14], osteosarcoma [13], and gastric cancer [18]. Here, SLC38A1 is linked to colorectal cancer.